Table 2.

Clinical efficacy of BNZ-1 in patients with T-LGLL

Objective responseN = 20 (%)
Partial response 4 (20) 
Transfusion-dependent anemia 3 (75) 
Neutropenia 1 (25) 
Progressive disease 16 (80) 
Overall response rate 4 (20) 
Objective responseN = 20 (%)
Partial response 4 (20) 
Transfusion-dependent anemia 3 (75) 
Neutropenia 1 (25) 
Progressive disease 16 (80) 
Overall response rate 4 (20) 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal